Caris Life Sciences (CAI) Cash Flow: Operating & Free Cash Flow

Caris Life Sciences Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Caris Life Sciences, Inc. (CAI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	-68.09	-281.89	-341.42	-320.83	27.73	31.01	78.60	72.06
Depreciation & Amortization	22.62	48.91	49.00	48.25	110.65	113.93	123.48	113.26
Deferred Income Tax	0.00	0.00	0.00	0.00	1.37	3.73	2.47	-14.95
Stock Based Compensation	70.01	18.64	15.24	22.90	1.78	2.76	2.87	2.09
Change in Working Capital	-33.13	-29.07	-7.13	-22.26	-317.31	417.23	-85.92	-90.74
Change in Accounts Receivable	-29.79	-33.82	-15.08	-11.91	11.00	3.86	-19.27	-7.80
Change in Inventory	-20.75	5.46	-4.44	-11.10	0.00	0.00	138.85	38.86
Change in Accounts Payable	11.04	-0.23	7.17	8.91	0.00	0.00	0.02	-2.21
Change in Other Working Capital	-5.10	16.69	3.96	6.98	-328.31	413.37	-205.51	-119.59
Other Operating Activities	91.75	16.69	8.20	6.98	452.80	-314.67	58.28	73.47
Net Cash from Operating Activities	83.16	-245.20	-276.10	-285.71	277.02	254.00	179.77	155.19
Investing Activities
Capital Expenditures	-16.26	-8.44	-22.32	-42.26	-219.45	-319.14	-812.84	-502.18
Purchases of Investments	0.00	0.00	-63.40	-378.38	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	0.00	61.38	300.49	137.65	0.00	0.00	43.35	24.06
Other Investing Activities	0.00	0.00	0.00	0.00	185.48	47.27	106.15	66.36
Net Cash from Investing Activities	-16.26	52.93	214.77	-282.99	-33.97	-271.87	-663.34	-411.75
Financing Activities
Debt Repayment	16.05	-0.16	-180.00	-0.96	0.00	0.00	0.00	0.00
Common Stock Issued	536.10	0.00	1.87	11.41	0.16	0.00	103.43	28.03
Common Stock Repurchased	-18.66	0.00	0.00	0.00	-7.95	-34.12	-40.87	0.00
Dividends Paid	0.00	0.00	0.00	0.00	-17.71	-8.83	-3.26	0.00
Other Financing Activities	-1.44	-1.06	-2.30	-0.96	-232.18	-99.65	515.61	245.63
Net Cash from Financing Activities	664.99	200.29	10.13	10.45	-249.88	-108.48	512.35	245.63
Summary
Effect of Forex Changes on Cash	0.13	0.00	0.06	0.00	0.10	0.18	0.00	0.22
Net Change in Cash	732.01	8.02	-51.13	-558.25	-6.74	-2.74	28.77	-10.71
Cash at Beginning of Period	68.03	60.01	111.14	669.38	73.24	75.98	47.21	46.13
Cash at End of Period	800.04	68.03	60.01	111.14	66.50	73.24	75.98	35.42
Free Cash Flow	66.90	-253.64	-298.42	-327.96	57.57	-65.15	-633.07	-346.98
Supplemental Disclosures
Interest Paid	-	49.02	15.78	24.24	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Caris Life Sciences Cash Flow

What is Caris Life Sciences's free cash flow?

Caris Life Sciences generated free cash flow of $66.89M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $83.16M minus $16.26M of capital expenditures. Free cash flow equaled 8.2% of revenue.

How much does Caris Life Sciences spend on capital expenditures?

Caris Life Sciences spent $16.26M on capital expenditures in fiscal 2025, compared with $8.44M a year earlier. That equals 19.6% of operating cash flow.

Does Caris Life Sciences pay dividends or buy back shares?

Yes. In fiscal 2025 Caris Life Sciences returned $18.66M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition